NEW YORK – August 4, 2022 – The Cardiovascular Research Foundation (CRF) has announced the late-breaking clinical science that will be presented at TCT 2022 . TCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine. It will take place September 16-19 in Boston, Massachusetts at the Boston Convention and Exhibition Center.
Every year, TCT features cutting-edge research in interventional cardiovascular medicine that directly impacts patient care and how physicians treat heart disease. The 32 studies selected examine the safety and effectiveness of minimally invasive techniques, pharmaceuticals, technologies, and devices that demonstrate potential to treat or prevent cardiovascular disease. Late-breaking science will be presented in the Clinical Science and Endovascular Theater and highlighted during press conferences scheduled for Saturday, September 17, Sunday, September 18, and Monday, September 19.
The full Program Guide can be found here: https://tct2022.crfconnect.com/program-guide . Media are invited to attend TCT and can apply for media credentials at: https://tct2022.crfconnect.com/press-registration .
Saturday, September 17, 2022
Sunday, September 18, 2022
Monday, September 19, 2022
Receive updates on Twitter at http://twitter.com/TCTConference and http://twitter.com/crfheart .
About CRF and TCT
The Cardiovascular Research Foundation (CRF) is one of the world’s leading nonprofit organizations specializing in interventional cardiology innovation, research, and education. CRF is dedicated to helping doctors improve survival and quality of life for people suffering from heart and vascular disease. For over 30 years, CRF has helped accelerate medical breakthroughs and educated doctors on the latest treatments for heart disease. CRF’s centers of excellence include the CRF Skirball Center for Innovation, CRF Clinical Trials Center, CRF Center for Education, CRF Digital, TCTMD, and Structural Heart: The Journal of the Heart Team .
Transcatheter Cardiovascular Therapeutics (TCT) is the annual scientific symposium of CRF and the premier educational meeting specializing in interventional cardiovascular medicine. Now in its 34 th year, TCT features major medical research breakthroughs and gathers leading researchers and clinicians from around the world to present and discuss the latest evidence-based research in the field.
For more information, visit www.crf.org and www.tctconference.com .
###